Ten top tips: realistic expectations about amputation

Authors:

Margaret Doucette and Stephanie Seabolt

Margaret Doucette is Associate Chief of Staff for Research at Boise VA Medical Center and Medical Director for the Wound/High Risk Foot/ Amputee Program. Clinical Associate Professor Univ of Washington, US;

Stephanie Seabright is Registered Nurse Clinical Research Coordinator at the Boise VA Medical Center working in wound/high risk foot clinic and Masters of Science in Nursing graduate student at Western Governor’s University, US Am putation of a lower extremity can be devastating, debilitating and demoralising, or it can be a successful, beneficial, definitive end point to a nonhealing diabetic foot ulcer (DFU). The decisionmaking process of if, and when, to amputate begins at the first patient visit and should be incorporated into the patient discussion early on for all high-risk patients. While prevention of amputation is most commonly the goal, early identification of risk factors and risk stratification can help design a realistic care plan, compassionately inform patient expectations and steward resource allocation. These 10 top tips will help guide you with the plan of care.

Physiotherapists’ knowledge and use of electrotherapy in the management of chronic wounds

Chronic wounds are becoming of public health concern, and despite extensive literature supporting the use of electrotherapy in the management of chronic wounds, Nigerian physiotherapists are rarely involved in wound care. This study sought to determine physiotherapists’ knowledge and use of electrotherapy in wound management. It used a self-administered questionnaire to collect information from physiotherapists in various practice settings. It was found that the majority of respondents (98.7%) had a good understanding of the role of electrotherapy in wound care, but had a poor understanding of both precaution (10.2%) and wound assessment (7.9%). Only 11.8% of physiotherapists were found to be involved in wound care and there was no association between knowledge and job rank (P =0.27).

Author:

Chioma Lynn Onuchukwu

Chioma Lynn Onuchukwu is Chief Physiotherapist, Enugu State University Teaching Hospital, Enugu, Nigeria

Phage therapy for diabetic foot infection

      The treatment of diabetic foot infections (DFIs) represents a costly and growing challenge to the NHS. DFIs can be difficult to treat for a variety of reasons, including late presentation of advanced infection, and antibiotic tolerance or resistance. Bacteriophage (phage) are ubiquitous viruses that infect and kill bacteria in a species-, sometimes even strain-, specific manner. Phages have been used to treat bacterial infection since 1919, but their use in the geopolitical West ceased in the 1930s due to a variety of factors, including the mass production of antibiotics. The modern antibiotic resistance crisis has driven renewed interest in phage therapy and 2,241 patients with mostly with antibiotic refractory infections have been treated since 2000, 79% of whom improved. This includes at least 310 patients with chronic wound infections, among whom 86.1% achieved clinical resolution or improvement of infection. Reassuringly, the available evidence suggests that phage therapy is safe and without notable side effects. Some phages also possess enzymes capable of degrading the biofilms that afford antibiotic tolerance to bacteria and underpin many chronic infections. Phages also act independent of antibiotic resistance, allowing the treatment of even pan-resistant bacteria, and topical or local application to DFIs means antimicrobial activity is independent of a patient’s peripheral perfusion. Presently only an option when antibiotics are not meeting a patient’s clinical needs, future integration of phage therapy at all levels of DFI care will radically transform the outlook for DFIs in the UK. Reducing the number of serious infections and amputations will not only benefit patients but will deliver vast savings to the NHS and reduce the amount of antibiotics used, making phage therapy a tangible response to the antibiotic resistance crisis.

Authors:

Matthew J Young, Lesley ML Hall and Joshua D Jones

This article first appeared in our sister publication, The Diabetic Foot Journal, in the November 2022 issue. Citation: Young MJ, Hall LML, Jones JD (2022) Phage therapy for diabetic foot infection 25(4): 30–7

Matthew J. Young is Consultant Physician, Royal Infirmary of Edinburgh, Edinburgh, UK;

Lesley ML Hall is Consultant Physician, Diabetes and Endocrinology, Queen Elizabeth University Hospital, Glasgow, UK;

Joshua D Jones is Consultant Physician, Infection Medicine, Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, UK; Clinical Microbiology, Ninewells Hospital, NHS Tayside, Dundee, UK

Meeting patients’ needs and healing wounds sooner: Using NICE guidance to deliver gold standard care

ABSTRACT: One of the most common questions asked to specialist healthcare professionals and educators in wound management is how to choose a suitable dressing. The importance of holistic assessment and diagnosis to accurately identify wound aetiology, the effect of comorbidities and associated risks for non-healing is paramount. This initial holistic assessment should be the starting point and given continued consideration throughout the wound healing process. In practical terms it is also acknowledged that there is a basic need for an appropriate wound dressing that will promote a moist wound healing environment, prepare the wound bed and prevent infection, all factors known to be important for progression of the wound healing process (Dowsett and Hall, 2019). It is therefore important that healthcare professionals delivering wound care are confident in the wound assessment process and in choosing a dressing that is going to promote wound healing and minimise the risk of wound complications.

KEY WORDS

NICE guidance

Nano-Oligosaccharide Factor (NOSF)

Wound care

UrgoStart Plus Treatment Range

JOY TICKLE

sTissue Viability Nurse Consultant Isle of Wight NHS Trust.

Management of wounds in Indian patients with poly-absorbent fibres impregnated with a silver lipidocolloid matrix dressing — a case series

Wound infections and biofilms play a significant role in delaying wound healing and present a challenge in chronic wound management. The presence of sloughy tissue is a prominent feature in these wounds and is considered a barrier against successful wound healing. Effective wound care integrates evidence-based dressings that provides continuous cleaning, antimicrobial activity and thus, is also effective against biofilms. Poly-absorbent fibres impregnated with a silver lipido-colloid matrix dressing has shown good outcomes, both in vitro and in vivo, in the management of slough and biofilm in wounds. The evidence originates from Europe and the authors of this case series attempted to assess the dressing in wounds from different regions of India to evaluate if positive results would be obtained.

Authors:

Anoop Vasudevan Pillai, Riju R Menon, KVNN Santosh Murthy, Divya Prakash, Sangeetha Kalabhairav, Anshumali Misra and Bhavin Ram

Anoop Vasudevan Pillai is Assistant Professor, Department of General Surgery, Amrita Institute of Medical Sciences, Kochi, Kerala, India;

Riju R Menon is Professor Department of General Surgery, Amrita Institute of Medical Sciences, Kochi, Kerala, India;

KVNN Santosh Murthy is Consultant General, Podiatric & Burns Surgeon, Advanced Wound Healing Clinics, Nalgonda, Telangana state, India; Founder of Advanced Wound Healing Clinics, Nalgonda, Telangana State, India;

Divya Prakash is Consultant Plastic Surgeon, Kauvery Hospital, Trichy, India;

Sangeetha Kalabhairav is Diabetic Foot, Nail Surgeon and Podiatrist; Sushrutha Multi-speciality Hospital, Vidyanagar, Hubli, India;

Anshumali Misra is Senior Consultant Plastic Microvascular and Cosmetic Surgery Max Hospital, New Delhi, India;

Bhavin Ram is Consultant Vascular and Endovascular Surgeon, Yashoda Hospitals, Secunderabad, Hyderabad, India

Development of aids for sharp debridement training in wound care

      The European Wound Management Association (EWMA) 2020 Level Seven curriculum recommends the provision of training on sharp debridement, primarily targeting specialist practitioners in wound care. Given the current lack of regulation for wound specialists in the UK, the quality and fidelity of training play a crucial role in health professionals' confidence when performing sharp debridement. Consequently, it is vital that training aids and methods accurately represent the realities of this procedure. Existing literature outlines training approaches using animal tissue or grapefruit models for sharp debridement. The University of Salford has developed a new simulation aid to teach tissue viability students about sharp debridement. This article details the development process and the creation of this innovative training aid designed to support sharp debridement education. The proposed simulation aid enables accurate representation of various wound tissue types requiring debridement in clinical settings, while eliminating the production of organic waste and the need for animal products, which may be objectionable to some learners.

KEY WORDS：Necrosis Sharp debridement Simulation Slough Wound

MATTHEW WYNN Lecturer in Adult Nursing, University of Salford

Correspondence: Room 3.42 Mary Seacole Building, University of Salford, Salford

 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 DANIELLE MAYO Clinical skills technician, University of Salford